Table Of Contents
1 Introduction 26
1.1 Objectives Of The Study 26
1.2 Market Definition 26
1.3 Overview Of Global Transradial Access Market 26
1.4 Currency And Pricing 27
1.5 Limitation 27
1.6 Markets Covered 28
2 Market Segmentation 30
2.1 Markets Covered 30
2.2 Geographic Scope 31
2.3 Years Considered For The Study 32
2.4 Currency And Pricing 32
2.5 Research Methodology 33
2.6 Primary Interviews With Key Opinion Leaders 36
2.7 Secondary Sources 37
2.8 Assumptions 37
3 Market Overview 38
3.1 Drivers 40
3.1.1 Increasing Cases Of Obese Patients 40
3.1.2 Rising Number Of Heart Problems 41
3.1.3 Growing Use Of Radial Access In Oncology Field 42
3.1.4 Technological Adavancements 43
3.2 Restraints 44
3.2.1 Product Recalls And Failures 44
3.3 Opportunities 45
3.3.1 Emerging Markets 45
3.4 Challenges 46
3.4.1 Side Effects Of Transradial Access 46
3.4.2 Lack Of Skilled Professsionals 46
4 Executive Summary 47
5 Premium Insights 50
?
6 Global Transradial Access Market, By Product 59
6.1 Overview 60
6.2 Sheaths And Sheath Introducers 62
6.3 Mircrocatheters 63
6.4 Guidewires 64
6.5 Guiding Catheters 65
6.6 Intermediate Catheters 66
6.7 Accessories 67
7 Global Transradial Access Market, By Application 68
7.1 Overview 69
7.2 Cardiology 71
7.3 Peripheral Vascular 72
7.4 Neurovascular 73
8 Global Transradial Access Market, By Usage 74
8.1 Overview 75
8.2 Drug Administration 77
8.3 Fluid And Nutrition Administration 79
8.4 Diagnostics And Testing 81
8.5 Blood Transfusion 83
9 Global Transradial Access Market, By End User 85
9.1 Overview 86
9.2 Hospital 88
9.3 Clinics 89
9.4 Ambulatory Care Centers 90
9.5 Others 91
10 Global Transradial Access System Market, By Geography 92
10.1 Overview 93
10.2 North America 100
10.2.1 U.S. 110
10.2.2 Canada 115
10.2.3 Mexico 120
10.3 Europe 125
10.3.1 Germany 135
10.3.2 France 140
10.3.3 U.K. 145
10.3.4 Italy 150
10.3.5 Spain 155
10.3.6 Switzerland 160
10.3.7 Netherlands 165
10.3.8 Turkey 170
10.3.9 Belgium 175
10.3.10 Russia 180
10.3.11 Rest Of Europe 185
10.4 Asia- Pacific 186
10.4.1 Japan 196
10.4.2 China 201
10.4.3 India 206
10.4.4 South Korea 211
10.4.5 Australia 216
10.4.6 Singapore 221
10.4.7 Thailand 226
10.4.8 Malaysia 231
10.4.9 Indonesia 236
10.4.10 Philippines 241
10.4.11 Rest Of Asia-Pacific 246
10.5 South America 247
10.5.1 Brazil 257
10.5.2 Rest Of South America 262
10.6 Middle East And Africa 263
10.6.1 South Africa 273
10.6.2 Rest Of Middle East And Africa 278
11 Global Transradial Access Market, Company Landscape 279
11.1 Company Share Analysis; Global 279
11.2 Company Share Analysis; North America 280
11.3 Company Share Analysis; Europe 281
11.4 Company Share Analysis; Asia Pacific 282
?
12 Company Profiles 283
12.1 Cardinal Health 283
12.1.1 Company Overview 283
12.1.2 Revenue Analysis ; Cardinal Health 283
12.1.3 Product Portfolio 284
12.1.7 Recent Developments Recent Developments 285
12.2 Stryker 286
12.2.1 Company Overview 286
12.2.2 Revenue Analysis; Stryker 286
12.2.3 Product Portfolio 287
12.2.7 Recent Developments 287
12.3 Angiodynamics Inc 288
12.3.1 Company Overview 288
12.3.2 Revenue Analysis ; Angiodynamics Inc 288
12.3.3 Product Portfolio 289
12.3.7 Recent Developments 289
12.4 Bd 290
12.4.1 Company Overview 290
12.4.2 Revenue Analysis ; Bd 290
12.4.3 Product Portfolio 291
12.4.7 Recent Developments 291
12.5 Amecath 292
12.5.1 Company Overview 292
12.5.2 Company Snapshot; Amecath 292
12.5.3 Product Portfolio 293
12.5.4 Recent Developments 293
12.6 Boston Scientific Corporation 294
12.6.1 Company Overview 294
12.6.2 Revenue Analysis ; Boston Scientific Corporation 294
12.6.3 Product Portfolio 295
12.6.4 Recent Developments 295
12.7 Edwards Lifesciences Corporation 296
12.7.1 Company Overview 296
12.7.2 Revenue Analysis ; Edwards Lifesciences Corporation 296
12.7.3 Product Portfolio 297
12.7.4 Recent Developments 297
12.8 Medtronic 298
12.8.1 Company Overview 298
12.8.2 Revenue Analysis ; Medtronic 298
12.8.3 Product Portfolio 299
12.8.4 Recent Developments 299
12.9 Merit Medical Systems Inc. 300
12.9.1 Company Overview 300
12.9.2 Revenue Analysis; Merit Medical Systems Inc. 300
12.9.3 Product Portfolio 301
12.9.4 Recent Developments 301
12.10 Nipro Corporation 302
12.10.1 Company Overview 302
12.10.2 Revenue Analysis ; Nipro Corporation 302
12.10.3 Product Portfolio 303
12.10.4 Recent Developments 303
12.11 Oscor Inc 304
12.11.1 Company Overview 304
12.11.2 Company Snapshot; Oscor Inc; 304
12.11.3 Roduct Portfolio 304
12.11.4 Recent Developments 305
12.12 Penumbra 306
12.12.1 Company Overview 306
12.12.2 Revenue Analysis; Penumbra 306
12.12.3 Product Portfolio 307
12.12.4 Recent Developments 307
12.13 Smiths Group Plc 308
12.13.1 Company Overview 308
12.13.2 Revenue Analysis ; Smiths Group Plc 308
12.13.3 Product Portfolio 309
12.13.4 Recent Developments 309
12.14 Teleflex Incorporated 310
12.14.1 Company Overview 310
12.14.2 Revenue Analysis ; Teleflex Incorporated 310
12.14.3 Product Portfolio 311
12.14.4 Recent Developments 311
12.15 Terumo Corporation 312
12.15.1 Company Overview 312
12.15.2 Revenue Analysis ; Terumo Corporation 312
12.15.3 Product Portfolio 313
12.15.4 Recent Developments Recent Developments 314
13 Related Reports 315
?